newsfilter
← Latest News
Business Wire·

Delcath Systems Reports First Quarter 2026 Results and Business Highlights

2026 Revenue Guidance of at least $100M Conference Call Today at 8:30 a.m. Eastern Time Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic